価格表
在庫・価格 ： 2024年05月21日 07時34分 現在
| 商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
|---|---|---|---|---|---|---|
|
Cystatin C, Mouse, ELISA Kit (96well) データシート |
RD291009200R |
BLMバイオベンダー ラボラトリー BioVendor Laboratory Medicine, Inc. |
1 kit | ¥108,000 |
無 (未発注) |
追加 |
在庫・価格 ： 2024年05月21日 07時34分 現在
使用文献
| No. | 文献情報 | 備考 | 参照 |
|---|---|---|---|
| 1 |
Gallo LA et al. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Sci Rep 2016 May;6:26428 Gallo LA et al 2016/01/01 |
 |
|
| 2 |
Jang HR et al. B cells limit repair after ischemic acute kidney injury. J. Am. Soc. Nephrol. 2010 Apr;21(4):654-65 Jang HR et al 2010/01/01 |
|
|
| 3 |
Rieger A et al. Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3L423P Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle. PLoS ONE 2016;11(7):e0158977 Rieger A et al 2016/01/01 |
|
|
| 4 |
Voelkl J et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J. Clin. Invest. 2013 Feb;123(2):812-22 Voelkl J et al 2013/01/01 |
|
|
| 5 |
Ward MS et al. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. Sci Rep 2017 11;7(1):15190 Ward MS et al 2017/01/01 |
|
|
| 6 |
Yoshida T et al. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease. J Am Heart Assoc 2017 Nov;6(11) Yoshida T et al 2017/01/01 |
|
|
| 7 |
Watson AMD et al. Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Front Physiol 2019;10:309 Watson AMD et al 2019/01/01 |
|
|
| 8 |
Jha JC et al. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia 2016 Feb;59(2):379-89 Jha JC et al 2016/01/01 |
|
- No.： 1
-
文献情報：
Gallo LA et al. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Sci Rep 2016 May;6:26428
Gallo LA et al
2016/01/01
-
備考：
-
参照：
- No.： 2
-
文献情報：
Jang HR et al. B cells limit repair after ischemic acute kidney injury. J. Am. Soc. Nephrol. 2010 Apr;21(4):654-65
Jang HR et al
2010/01/01
-
備考：
-
参照：
- No.： 3
-
文献情報：
Rieger A et al. Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3L423P Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle. PLoS ONE 2016;11(7):e0158977
Rieger A et al
2016/01/01
-
備考：
-
参照：
- No.： 4
-
文献情報：
Voelkl J et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J. Clin. Invest. 2013 Feb;123(2):812-22
Voelkl J et al
2013/01/01
-
備考：
-
参照：
- No.： 5
-
文献情報：
Ward MS et al. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. Sci Rep 2017 11;7(1):15190
Ward MS et al
2017/01/01
-
備考：
-
参照：
- No.： 6
-
文献情報：
Yoshida T et al. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease. J Am Heart Assoc 2017 Nov;6(11)
Yoshida T et al
2017/01/01
-
備考：
-
参照：
- No.： 7
-
文献情報：
Watson AMD et al. Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Front Physiol 2019;10:309
Watson AMD et al
2019/01/01
-
備考：
-
参照：
- No.： 8
-
文献情報：
Jha JC et al. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia 2016 Feb;59(2):379-89
Jha JC et al
2016/01/01
-
備考：
-
参照：